DiVincenzo Jonathan P. 4
4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed Mar 29, 2024
Insider Transaction Report
Form 4
DiVincenzo Jonathan
EVP, Pres, Central Labs & Intl
Transactions
- Tax Payment
Common Stock
2024-03-27$216.57/sh−952$206,175→ 5,460.549 total - Exercise/Conversion
Restricted Stock Unit
2024-03-27−3,012→ 1,965 total→ Common Stock (3,012 underlying) - Exercise/Conversion
Common Stock
2024-03-27+3,012→ 6,412.549 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024.
- [F4]This number reflects the aggregate number of RSUs held by the reporting person.